See more : Vertex Pharmaceuticals Incorporated (VRTX) Income Statement Analysis – Financial Results
Complete financial analysis of Aker BioMarine AS (AKBM.OL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aker BioMarine AS, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Delta Manufacturing Limited (DELTAMAGNT.NS) Income Statement Analysis – Financial Results
- ReoStar Energy Corp. (REOS) Income Statement Analysis – Financial Results
- MERCK Kommanditgesellschaft auf Aktien (MRK.DE) Income Statement Analysis – Financial Results
- Taronis Fuels, Inc. (TRNF) Income Statement Analysis – Financial Results
- Mineral & Financial Investments Limited (MAFL.L) Income Statement Analysis – Financial Results
Aker BioMarine AS (AKBM.OL)
About Aker BioMarine AS
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 335.30M | 277.20M | 262.06M | 288.59M | 246.17M | 154.18M | 125.54M | 116.74M | 105.12M | 112.30M | 108.99M | 84.00M | 55.29M | 52.05M | 25.02M | 12.19M | 74.05M |
| Cost of Revenue | 222.40M | 162.40M | 174.00M | 179.01M | 150.89M | 89.93M | 75.40M | 51.16M | 56.75M | 80.26M | 93.68M | 46.39M | 16.59M | 12.93M | 10.87M | 1.29M | 40.79M |
| Gross Profit | 112.90M | 114.80M | 88.06M | 109.58M | 95.28M | 64.26M | 50.15M | 65.57M | 48.37M | 32.04M | 15.31M | 37.61M | 38.70M | 39.12M | 14.15M | 10.90M | 33.26M |
| Gross Profit Ratio | 33.67% | 41.41% | 33.60% | 37.97% | 38.70% | 41.67% | 39.94% | 56.17% | 46.01% | 28.53% | 14.05% | 44.78% | 70.00% | 75.16% | 56.55% | 89.41% | 44.91% |
| Research & Development | 690.00K | 4.00M | 2.96M | 3.91M | 5.40M | 9.07M | 0.00 | 3.50M | 2.10M | 8.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 21.00M | 14.80M | 19.18M | 17.21M | 20.10M | 15.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.34M |
| Selling & Marketing | 69.10M | 67.70M | 63.57M | 65.74M | 48.31M | 20.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 918.78K |
| SG&A | 90.50M | 82.50M | 82.75M | 82.94M | 68.41M | 36.34M | 32.93M | 30.03M | 22.65M | 25.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.26M |
| Other Expenses | 16.41M | 9.10M | 16.45M | 17.94M | 19.82M | 8.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.30M | 48.08M | 46.10M | 50.39M | 37.72M | -367.51K |
| Operating Expenses | 107.60M | 95.60M | 102.16M | 104.78M | 93.63M | 54.00M | 51.83M | 59.65M | 40.43M | 42.57M | 7.74M | 40.30M | 48.08M | 46.10M | 50.39M | 37.72M | 60.64M |
| Cost & Expenses | 330.00M | 258.00M | 276.16M | 283.79M | 244.53M | 143.92M | 127.22M | 110.82M | 97.18M | 122.83M | 101.42M | 86.69M | 64.67M | 59.02M | 61.26M | 39.01M | 101.43M |
| Interest Income | 2.40M | 600.00K | 21.00K | 876.00K | 1.09M | 32.00K | 15.07M | 7.40M | 7.05M | 6.63M | 8.40M | 0.00 | 3.02M | 2.04M | 11.04M | 42.16M | 10.29M |
| Interest Expense | 33.40M | 20.30M | 13.68M | 18.74M | 22.79M | 12.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.87M | 9.55M | 17.69M | 20.88M | 53.06M | 16.91M |
| Depreciation & Amortization | 50.20M | 49.40M | 53.00M | 48.25M | 36.95M | 22.86M | 16.40M | 16.40M | 15.53M | 18.02M | 14.82M | 19.70M | 9.88M | 11.23M | 10.87M | 7.89M | 13.60M |
| EBITDA | 49.70M | 81.90M | 59.30M | 67.67M | 36.40M | 33.84M | 15.06M | 32.59M | 25.34M | 6.45M | 11.85M | 19.52M | 502.61K | -2.21M | -13.98M | 23.23M | 20.95M |
| EBITDA Ratio | 14.82% | 27.27% | 21.72% | 23.12% | 14.33% | 22.90% | 12.00% | 27.92% | 24.10% | 5.75% | 10.88% | 27.51% | 0.91% | 12.75% | -56.55% | 190.59% | -9.43% |
| Operating Income | 5.30M | 22.10M | 5.85M | 18.47M | -1.67M | 10.26M | -1.34M | 16.19M | 9.81M | -11.57M | -2.96M | -6.27M | -9.38M | -13.27M | -42.62M | -26.82M | -27.38M |
| Operating Income Ratio | 1.58% | 7.97% | 2.23% | 6.40% | -0.68% | 6.65% | -1.07% | 13.87% | 9.33% | -10.30% | -2.72% | -7.46% | -16.97% | -25.49% | -170.34% | -220.00% | -36.97% |
| Total Other Income/Expenses | -39.20M | -9.90M | 6.30M | -17.78M | -21.67M | -11.54M | -15.42M | -9.94M | -7.03M | -4.11M | 27.50M | -5.19M | -9.55M | -15.31M | -9.66M | -10.90M | -2.21M |
| Income Before Tax | -33.90M | 12.20M | -7.40M | 688.00K | -23.34M | -1.28M | -16.76M | -1.48M | 887.00K | -17.16M | 14.65M | -11.46M | -18.93M | -28.75M | -52.46M | -37.72M | -37.49M |
| Income Before Tax Ratio | -10.11% | 4.40% | -2.83% | 0.24% | -9.48% | -0.83% | -13.35% | -1.27% | 0.84% | -15.28% | 13.44% | -13.65% | -34.24% | -55.23% | -209.66% | -309.41% | -50.62% |
| Income Tax Expense | -25.00M | 2.20M | 604.00K | 6.15M | 415.00K | -259.00K | 1.01M | 573.00K | 82.00K | 101.00K | 31.94M | 358.22K | 9.55M | -51.20M | 6.56M | 11.62M | -8.27M |
| Net Income | -9.00M | 10.00M | -8.01M | -5.46M | -23.75M | -1.02M | -17.77M | -2.06M | 805.00K | -17.26M | 46.59M | -11.82M | -18.93M | 28.92M | -52.46M | -61.81M | -29.22M |
| Net Income Ratio | -2.68% | 3.61% | -3.06% | -1.89% | -9.65% | -0.66% | -14.15% | -1.76% | 0.77% | -15.37% | 42.75% | -14.07% | -34.24% | 55.56% | -209.66% | -507.06% | -39.45% |
| EPS | -0.10 | 0.11 | -0.09 | -0.07 | -0.34 | -0.02 | 0.00 | -0.03 | 0.01 | -0.25 | 0.00 | -0.01 | -0.02 | 0.05 | -0.58 | -0.69 | -0.38 |
| EPS Diluted | -0.10 | 0.11 | -0.09 | -0.07 | -0.34 | -0.01 | 0.00 | -0.03 | 0.01 | -0.25 | 0.00 | -0.01 | -0.02 | 0.05 | -0.58 | -0.69 | -0.38 |
| Weighted Avg Shares Out | 87.66M | 87.63M | 87.59M | 78.06M | 69.05M | 68.00M | 0.00 | 68.50M | 80.51M | 69.03M | 0.00 | 1.11B | 955.38M | 528.40M | 90.11M | 90.11M | 76.04M |
| Weighted Avg Shares Out (Dil) | 87.66M | 90.00M | 87.59M | 78.06M | 69.05M | 69.05M | 0.00 | 69.05M | 69.05M | 69.05M | 0.00 | 1.11B | 955.38M | 528.40M | 90.11M | 90.11M | 76.04M |
Source: https://incomestatements.info
Category: Stock Reports